STOCK TITAN

Howard Hughes (NYSE: HHH) director granted 3,290 restricted stock shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GRANDISSON MARC reported acquisition or exercise transactions in this Form 4 filing.

Howard Hughes Holdings Inc. director Marc Grandisson received a grant of 3,290 shares of common stock as restricted stock compensation under the company’s 2025 Equity Incentive Plan. These shares vest on the earlier of the 2027 annual stockholders meeting or June 1, 2027, and represent his entire reported direct holding.

Positive

  • None.

Negative

  • None.
Insider GRANDISSON MARC
Role null
Type Security Shares Price Value
Grant/Award Common stock, $0.01 par value 3,290 $0.00 --
Holdings After Transaction: Common stock, $0.01 par value — 3,290 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock grant 3,290 shares Restricted common stock awarded to director on June 19, 2026
Grant price $0.00 per share Reported transaction price for the restricted stock award
Post-transaction holdings 3,290 shares Total direct common stock held by Marc Grandisson after grant
Latest vesting date June 1, 2027 Shares vest by earlier of 2027 annual meeting or this date
restricted stock financial
"Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
2025 Equity Incentive Plan financial
"granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
non-employee directors financial
"Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GRANDISSON MARC

(Last)(First)(Middle)
9950 WOODLOCH FOREST DRIVE
SUITE 1100

(Street)
THE WOODLANDS TEXAS 77380

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Howard Hughes Holdings Inc. [ HHH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, $0.01 par value06/19/2026A3,290(1)A$03,290D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of the 2027 annual meeting of stockholders of Howard Hughes Holdings Inc. or June 1, 2027.
/s/ Nathan Bryce (Attorney-in-Fact for Marc Grandisson)06/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Howard Hughes Holdings (HHH) report for Marc Grandisson?

Howard Hughes Holdings reported that director Marc Grandisson received 3,290 shares of restricted common stock as a compensation grant. The award was made at no cash cost to him and reflects non-employee director equity under the 2025 Equity Incentive Plan.

Was the Howard Hughes (HHH) Marc Grandisson Form 4 a stock purchase or a grant?

The Form 4 for Marc Grandisson reports a stock grant, not an open-market purchase. He acquired 3,290 restricted shares as a compensation award under the 2025 Equity Incentive Plan at a reported price of $0.00 per share.

When do Marc Grandisson’s restricted Howard Hughes (HHH) shares vest?

Marc Grandisson’s 3,290 restricted shares vest on the earlier of the 2027 annual meeting of stockholders or June 1, 2027. Until vesting, the shares remain subject to the restrictions described in the company’s 2025 Equity Incentive Plan.

How many Howard Hughes (HHH) shares does Marc Grandisson hold after this Form 4?

After this reported transaction, Marc Grandisson beneficially owns 3,290 shares of Howard Hughes common stock directly. All of these shares relate to the restricted stock grant disclosed in this filing and are subject to the specified vesting schedule.

What plan governs Marc Grandisson’s restricted stock grant at Howard Hughes (HHH)?

The restricted stock grant to Marc Grandisson was made under Howard Hughes Holdings Inc.’s 2025 Equity Incentive Plan. This plan provides equity-based compensation to non-employee directors, with vesting terms tied to future stockholder meetings or specified dates.